Each week, Rewire News Group editors scour headlines nationwide—from lawsuits over abortion access to LGBTQ rights—to bring you the most urgent news in reproductive justice. Here’s this week’s latest.

Mifepristone “review” was pushed by anti-abortion groups

The Food and Drug Administration will proceed with a safety review of mifepristone, one of two drugs commonly used in medication abortions, the Wall Street Journal first reported. CBS News reported on June 5, 2026 that an official confirmed the study will evaluate hundreds of thousands of cases retrospectively, and the White House claims the study has been underway for months. The FDA’s move is a win for anti-abortion groups, who........

© Rewire.News